Professor Dr. Ali Aldujeli
Lead Consultant General and Interventional Cardiologist
To refer a patient, please contact our office directly via phone or email. We require a referral letter from the primary care physician or specialist detailing the patient's medical history and the reason for referral. Our team will coordinate to schedule an appointment at the earliest convenience.
Monday to Friday: 9am to 5pm.
Clinic located in building behind the hospital
Suite 2 2nd Floor
Clinical Services Hub
Towlerton
Limerick
V948 92F
Monday to Friday: 9am to 5pm.
Bon Secours Hospital Limerick at Barringtons.
Bon Secours Hospital Galway
Management of a wide range of heart conditions, including chest pain, arrhythmias, and general cardiac issues.
Specialising in minimally invasive procedures to treat coronary artery diseases, such as angioplasty and stenting.
Focused on the treatment of coronary artery disease and its complications.
Management and treatment of heart conditions caused by high blood pressure.
Comprehensive care for patients with heart failure, including advanced therapies and devices.
Diagnosis and management of diseases affecting heart valves.
Strategies and treatments to prevent heart disease, including lifestyle modification and risk assessment.
Advanced imaging techniques to diagnose and manage heart conditions, including echocardiography and cardiac CTs.
Professor Dr. Ali Aldujeli is a distinguished General and Interventional Cardiologist, renowned for his expertise in managing general cardiology and ischemic heart diseases. With his exceptional dedication to patient-centered care, he is celebrated for addressing complex cardiovascular conditions with precision and compassion.
Professor Dr. Aldujeli believes in a holistic and empathetic approach to care. His patients consistently commend his ability to explain complex conditions in a clear and reassuring manner. For many, he has been a source of hope and confidence, providing tailored treatments that prioritize both their medical and emotional well-being.
In 2021, Professor Dr. Aldujeli was awarded a prestigious scholarship by the Ministry of Education to pursue PhD studies in Molecular Cardiology. He earned his degree in 2024 with distinction, focusing on the intricate mechanisms of coronary microcirculation dysfunction. His research yielded groundbreaking insights, significantly advancing the understanding and treatment of cardiovascular diseases.
Professor Dr. Aldujeli has authored over 120 peer-reviewed publications, establishing himself as a thought leader in cardiology. In addition to his extensive publication record in interventional cardiology, he has co-authored several notable cardiology textbooks. His work has influenced clinical practices globally, earning him invitations to present at leading conferences across Europe, the United States, and beyond.
Professor Dr. Aldujeli is deeply committed to educating the next generation of cardiologists. As an Professor, he has shaped the careers of numerous young physicians, fostering excellence and innovation in cardiovascular care. His contributions were recognized internationally in 2023 when he received the Certificate of Excellence in Teaching and Leadership.
In 2023, Professor Dr. Aldujeli was elected as a Fellow of the European Society of Cardiology (FESC). His achievements were further acknowledged in 2024 when he became a Fellow of the Heart Failure Association (FHFA) and was elected as a Fellow of the Society for Cardiovascular Angiography & Interventions (FSCAI). These accolades highlight his profound impact on interventional cardiology and his reputation as a leading expert in the field.
Professor Dr. Aldujeli completed an MSc program in Health Economics and Management in 2025 at the London School of Economics and Political Science (LSE), supported by scholarships from the European Society of Cardiology (ESC) and the European Heart Academy. This program has further enhanced his leadership and management skills, positioning him as a visionary in both clinical and administrative capacities.
Professor Dr. Ali Aldujeli welcomes patients seeking expert care in general and interventional cardiology. His dedication to providing individualized, world-class treatment ensures that every patient receives the highest standard of care. Whether addressing complex cardiovascular conditions or guiding patients on their journey to better health, Professor Dr. Aldujeli’s compassionate and innovative approach sets him apart as a trusted leader in cardiovascular medicine.
2025
Kurmanaliyev, A., Braukylienė, R., Aldujeli, A., Zhumagaliyev, R., Aitaliyev, S., & Unikas, R. (2025). Evaluating the impacts of Procedural and Patient-Specific factors on the outcomes of Transcatheter Aortic Valve Implantation (TAVI). Medicina, 61(1), 94. https://doi.org/10.3390/medicina61010094
2024
Aldujeli, A., Tsai, T., Haq, A., Tatarunas, V., Garg, S., Hughes, D., Ciapiene, I., Unikas, R., Sharif, F., Lesauskaite, V., Onuma, Y., & Serruys, P. W. (2024). The association between trimethylamine N-oxide levels and coronary microvascular dysfunction and prognosis in patients with ST-elevation myocardial infarction. Atherosclerosis, 398, 118597. https://doi.org/10.1016/j.atherosclerosis.2024.118597
Tsai, T. Y., Aldujeli, A., Haq, A., Knokneris, A., Briedis, K., Hughes, D., Unikas, R., Renkens, M., Revaiah, P. C., Tobe, A., Miyashita, K., Sharif, F., Garg, S., Onuma, Y., & Serruys, P. W. (2024). The Impact of Microvascular Resistance Reserve on the Outcome of Patients With STEMI. JACC: Cardiovascular Interventions. https://doi.org/10.1016/j.jcin.2024.03.024
Aldujeli, A., Tsai, T., Haq, A., Tatarunas, V., Knokneris, A., Briedis, K., Unikas, R., Onuma, Y., Brilakis, E. S., & Serruys, P. W. (2024). Impact of Coronary Microvascular Dysfunction on Functional Left Ventricular Remodeling and Diastolic Dysfunction. Journal of the American Heart Association, 13. http://dx.doi.org/10.1161/jaha.123.033596
2023
Haq, A., Veerati, T., Walser-Kuntz, E., Aldujeli, A., Tang, M., & Miedema, M. (2023). Coronary artery calcium and the risk of cardiovascular events and mortality in younger adults: a meta-analysis. European Journal of Preventive Cardiology. http://dx.doi.org/10.1093/eurjpc/zwad399
Aldujeli, A., Haq, A., Tsai, T-Y., Grabauskyte, I., Tatarunas, V., Briedis, K., Rana, S., Unikas, R., Hamadeh, A., Serruys, P. W., & Brilakis, E. S. (2023). The impact of primary percutaneous coronary intervention strategies during ST-elevation myocardial infarction on the prevalence of coronary microvascular dysfunction. Scientific Reports, 13. http://dx.doi.org/10.1038/s41598-023-47343-x
(More articles from 2022-2020 available upon request.)
Labanauskaitė, E., Aldujeli, A., & Unikas, R. (2022). Žarnyno mikrobiotos įtaka širdies ir kraujagyslių ligoms. Lithuanian General Practitioner, 26, 486–491. http://dx.doi.org/10.37499/lbpg.1038
Kurnickaitė, Ž., Aldujeli, A., Alšauskė, S. V., & Unikas, R. (2022). Mikrovaskulinė angina: klinika, diagnostika ir gydymas. Lithuanian General Practitioner, 26, 105–110. http://dx.doi.org/10.37499/lbpg.885
2021
Scholarship associated with Doctor of Philosophy (PhD) in Medicine, Cardiovascular Science – Issued by Ministry of Education
2022
Young Researcher of the Year Award – Issued by Research Affairs Department
2023
Certificate for Excellence in Teaching and Leadership Competencies – Issued by Director of Education, Sligo University Hospital
Scholarship for MSc in Health Economics and Management at the London School of Economics and Political Science (LSE) – Issued by the European Society of Cardiology & European Heart Academy
2024
Fellow of the European Society of Cardiology (FESC) – Awarded by the European Society of Cardiology in recognition of significant contributions to the field of cardiology and excellence in clinical practice
Fellow of the Society for Cardiovascular Angiography & Interventions (FSCAI) – Awarded by the Society for Cardiovascular Angiography & Interventions (USA) for excellence in interventional cardiology
2025
Fellow of the Heart Failure Association of the ESC (FHFA) – Awarded by the European Society of Cardiology & Heart Failure Association for contributions to the field of heart failure research and treatment